Heparin binding and oligomerization of hepatocyte growth factor/scatter factor isoforms. Heparan sulfate glycosaminoglycan requirement for Met binding and signaling - PubMed (original) (raw)
. 1997 Apr 4;272(14):9457-63.
doi: 10.1074/jbc.272.14.9457.
Affiliations
- PMID: 9083085
- DOI: 10.1074/jbc.272.14.9457
Free article
Heparin binding and oligomerization of hepatocyte growth factor/scatter factor isoforms. Heparan sulfate glycosaminoglycan requirement for Met binding and signaling
H Sakata et al. J Biol Chem. 1997.
Free article
Abstract
Hepatocyte growth factor/scatter factor (HGF/SF) is a heparin-binding polypeptide that stimulates cell proliferation, motility, and morphogenesis by activation of its receptor, the c-Met tyrosine kinase. HGF/SF consists of a series of structural units, including an amino-terminal segment with a hairpin loop, four kringle domains, and a serine protease-like region. In this study, we demonstrate that the amino-terminal (N) domain retains the heparin-binding properties of full-length HGF/SF. In contrast to a previous hypothesis, selected basic amino acid residues in the hairpin loop are not critical for heparin binding, although alanine substitution at a subset of these sites markedly reduced the biological activity of the HGF/SF isoform, HGF/NK1. Covalent cross-linking experiments performed with wild-type and heparan sulfate glycosaminoglycan (HSGAG)-deficient Chinese hamster ovary (CHO) cells revealed that Met-HGF/NK1 binding was strongly dependent on HSGAG. Addition of heparin to HSGAG-deficient CHO cells not only restored ligand binding, but also increased ligand-dependent Met tyrosine phosphorylation and c-fos expression. Moreover, our results showed that heparin stimulated ligand oligomerization through an interaction with the N domain. These findings establish the importance of the N domain for heparin-ligand and ligand-ligand interactions, and demonstrate a crucial role for HSGAG in receptor binding and signal transduction.
Similar articles
- Hairpin loop and second kringle domain are essential sites for heparin binding and biological activity of hepatocyte growth factor.
Mizuno K, Inoue H, Hagiya M, Shimizu S, Nose T, Shimohigashi Y, Nakamura T. Mizuno K, et al. J Biol Chem. 1994 Jan 14;269(2):1131-6. J Biol Chem. 1994. PMID: 8288571 - Dissociation of heparan sulfate and receptor binding domains of hepatocyte growth factor reveals that heparan sulfate-c-met interaction facilitates signaling.
Rubin JS, Day RM, Breckenridge D, Atabey N, Taylor WG, Stahl SJ, Wingfield PT, Kaufman JD, Schwall R, Bottaro DP. Rubin JS, et al. J Biol Chem. 2001 Aug 31;276(35):32977-83. doi: 10.1074/jbc.M105486200. Epub 2001 Jul 2. J Biol Chem. 2001. PMID: 11435444 - Isolation and Characterization of a Chinese Hamster Ovary Heparan Sulfate Cell Mutant Defective in Both Met Receptor Binding and Hepatocyte Growth Factor NK1/Met Signaling.
Cao T, Pan J, Li X, He Y, Jiang Y, Chang Y, Zhang Q, Lan Y, Wang H, Jiao W, Tian Z, Zhang L. Cao T, et al. Cell Physiol Biochem. 2018;48(4):1480-1491. doi: 10.1159/000492258. Epub 2018 Aug 14. Cell Physiol Biochem. 2018. PMID: 30107380 - Identification of functional domains in the hepatocyte growth factor and its receptor by molecular engineering.
Bardelli A, Ponzetto C, Comoglio PM. Bardelli A, et al. J Biotechnol. 1994 Sep 30;37(2):109-22. doi: 10.1016/0168-1656(94)90002-7. J Biotechnol. 1994. PMID: 7765452 Review. - Signalling by HGF/SF and Met: the role of heparan sulphate co-receptors.
Kemp LE, Mulloy B, Gherardi E. Kemp LE, et al. Biochem Soc Trans. 2006 Jun;34(Pt 3):414-7. doi: 10.1042/BST0340414. Biochem Soc Trans. 2006. PMID: 16709175 Review.
Cited by
- Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action.
Finch PW, He X, Kelley MJ, Uren A, Schaudies RP, Popescu NC, Rudikoff S, Aaronson SA, Varmus HE, Rubin JS. Finch PW, et al. Proc Natl Acad Sci U S A. 1997 Jun 24;94(13):6770-5. doi: 10.1073/pnas.94.13.6770. Proc Natl Acad Sci U S A. 1997. PMID: 9192640 Free PMC article. - Functional and biophysical characterization of recombinant human hepatocyte growth factor isoforms produced in Escherichia coli.
Stahl SJ, Wingfield PT, Kaufman JD, Pannell LK, Cioce V, Sakata H, Taylor WG, Rubin JS, Bottaro DP. Stahl SJ, et al. Biochem J. 1997 Sep 15;326 ( Pt 3)(Pt 3):763-72. doi: 10.1042/bj3260763. Biochem J. 1997. PMID: 9307026 Free PMC article. - Analysis of the Effect of Increased α2,3-Sialylation on RTK Activation in MKN45 Gastric Cancer Spheroids Treated with Crizotinib.
Balmaña M, Diniz F, Feijão T, Barrias CC, Mereiter S, Reis CA. Balmaña M, et al. Int J Mol Sci. 2020 Jan 22;21(3):722. doi: 10.3390/ijms21030722. Int J Mol Sci. 2020. PMID: 31979110 Free PMC article. - State of the structure address on MET receptor activation by HGF.
Linossi EM, Estevam GO, Oshima M, Fraser JS, Collisson EA, Jura N. Linossi EM, et al. Biochem Soc Trans. 2021 Apr 30;49(2):645-661. doi: 10.1042/BST20200394. Biochem Soc Trans. 2021. PMID: 33860789 Free PMC article. Review. - Phenotypic alterations in Kaposi's sarcoma cells by antisense reduction of perlecan.
Marchisone C, Del Grosso F, Masiello L, Prat M, Santi L, Noonan DM. Marchisone C, et al. Pathol Oncol Res. 2000;6(1):10-7. doi: 10.1007/BF03032652. Pathol Oncol Res. 2000. PMID: 10749582
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous